Search results
Showing results for
Neutralising mAbs, a form of anti-viral medicine, are being explored as an attractive option to treat symptoms of COVID-19 and in some cases prevent infection. But what are the pros and cons of this type of treatment and what should regulators consider before granting approval?
Clinical Kennedy Trust Prize Studentships
Applications for these projects are now closed. Please visit the website in summer 2026 to see available projects for October 2027 entry.
Botnar projects
Applications for these projects are now closed. Please visit the website in summer 2026 to see available projects for October 2027 entry.